CoChat

New Applications of Heparin and Other Glycosaminoglycans

Open access

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Abstract

Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a century. Its introduction reduced clotting risks substantially and subsequent developments, including the introduction of low-molecular-weight heparin, made possible many major surgical interventions that today make heparin an indispensable drug. There has been a recent burgeoning of interest in heparin and related glycosaminoglycan (GAG) polysaccharides, such as chondroitin sulfates, heparan sulfate, and hyaluronate, as potential agents in various applications. This ability arises mainly from the ability of GAGs to interact with, and alter the activity of, a wide range of proteins. Here, we review new developments (since 2010) in the application of heparin and related GAGs across diverse fields ranging from thrombosis and neurodegenerative disorders to microbiology and biotechnology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules22050749

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 102 references

Research works printed but not linked: 2

  1. Gibbon, 1939, The maintenance of life during experimental occlusion of the pulmonary artery followed by survival, Surg Gynecol Obs., 69, 602
  2. Harenberg, J., and Casu, B. (2012). Nonanticoagulant Actions of Glycosaminoglycans, Springer US.

Cited by

Metadata

Authors
Lima, M., Rudd, T., & Yates, E.
Affiliations
University of Liverpool (GB)
Corresponding author
  • Lima, Marcelo
  • Rudd, Timothy
  • Yates, Edwin
Venue
Molecules
Publisher
MDPI AG
Published
2017-05-06
Volume
22
Issue
5
Pages
749
ISSN
1420-3049 (ISSN-L)
OpenAlex
W2610898931
Cited by
89
References
102
Citations by year
2026: 10 · 2025: 8 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 18 · 2020: 9 · 2019: 8 · 2018: 10 · 2017: 2
FWCI
0.92
Type
journal article
Language
en
Open access
Locations
  • Molecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Keele Research Repository (Keele University) (submittedVersion, cc-by)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Polysaccharides Composition and Applications
  • Physical Sciences › Materials Science › Surfaces, Coatings and Films › Polymer Surface Interaction Studies
Keywords
heparin, glycosaminoglycans, low molecular weight heparin, chondroitin sulfate, heparan sulfate, hyaluronic acid, anticoagulants, thrombosis, neurodegenerative diseases, protein binding, biotechnology applications
MeSH terms
Anticoagulants, Biotechnology, Glycosaminoglycans, Humans, Neoplasms, Thrombosis, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.